Masis Isikbay, MD's Publications

Arteriovenous shunts of the cervical spine: patient demographics, presentation, patterns of high-risk venous drainage, and updated classification.

MR Imaging in Cervical Spine Trauma: What You Need to Know in 2025!

Deep learning segmentation-based bone removal from computed tomography of the brain improves subdural hematoma detection.

The Importance of Clinical History in the Evaluation of Lumbar Spine Imaging.

The Role of US Elastography in Evaluating Thyroid Nodules.

A Deep Learning Approach for Automated Bone Removal from Computed Tomography Angiography of the Brain.

Challenges of Preparing for Diagnostic Radiology Call.

Tradeoffs associated with autotomy and regeneration and their potential role in the evolution of regenerative abilities.

Transitional vascular anomaly of a persistent medial procephalic vein causing obstructive hydrocephalus and intracranial haemorrhage.

Transvenous Approaches to the Vertebral-Venous Plexus for Endovascular Treatment of Cervical Epidural Arteriovenous Fistulas: Anatomy and Technique.

A different type of machine learning: optimizing ultrasound ergonomics during image guided procedures.

Computed tomography perfusion abnormalities after carotid endarterectomy help in the diagnosis of reversible cerebral vasoconstriction syndrome.

CT on the Diamond Princess: What Might This Tell Us About Sensitivity for COVID-19?

Traumatic testicular rupture: Multimodality imaging with intraoperative correlate.

Visceral Aneurysm Formation and Intraabdominal Hemorrhage Associated with Immune Checkpoint Inhibitor Therapy.

When to rule out COVID-19: How many negative RT-PCR tests are needed?

Family history of prostate cancer and the incidence of ERG- and phosphatase and tensin homolog-defined prostate cancer.

Abstract 4236: Gene expression profiling of prostate tissue identifies biological pathways associated with TMPRSS2:ERG gene fusion.

Metabolism of megestrol acetate in vitro and the role of oxidative metabolites.

Perineural Invasion and Risk of Lethal Prostate Cancer.

Acquired resistance to the second-generation androgen receptor antagonist enzalutamide in castration-resistant prostate cancer.

Abstract 2243: Alterations in the binding of Meis proteins to HoxB13 or to DNA promote prostate cancer progression.

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.

Molecular analysis of CD133-positive circulating tumor cells from patients with metastatic castration-resistant prostate cancer.

The effects of cheliped autotomy and regeneration on aggression in purple shore crabs (Hemigrapsus nudus).

Androgen receptor independent acquired mechanisms of resistance to enzalutamide in castration-resistant prostate cancer.

Feasibility of multimodal molecular characterization of the androgen receptor (AR) in circulating tumor cells (CTCs) from patients with castrate-resistant prostate cancer (CRPC).

Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer.

Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.

A size comparison of beta-galactosidase isolated from fibroblasts from normal and GM1-affected sheep.

Evaluation of GLB1 In a Novel Ovine Model of GM1-Gangliosidosis.